Part B Payment Model Indexing Commercial Discounts Proposed By Genentech

The US Centers for Medicare and Medicaid Services could bring more price competition to the Medicare Part B prescription drug market with a payment model in which manufacturers provide Medicare with the same deal as private payers, according to Genentech Inc.

The model would be tested before implementation but could be a better option for patients than approaches that more substantially disrupt the existing buy-and-bill supply chain, the company suggests in...